These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 28381381)

  • 1. Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding.
    Su AP; Zhang ZD; Tian BL; Zhu JQ
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):169-175. PubMed ID: 28381381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt (TIPS) versus laparoscopic splenectomy (LS) plus preoperative endoscopic varices ligation (EVL) in the treatment of recurrent variceal bleeding.
    Zhou J; Wu Z; Wu J; Wang X; Li Y; Wang M; Yang Z; Peng B; Zhou Z
    Surg Endosc; 2013 Aug; 27(8):2712-20. PubMed ID: 23392981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term outcomes of splenectomy with periesophagogastric devascularization and transjugular intrahepatic portosystemic shunt in treating cirrhotic portal hypertension patients with recurrent variceal bleeding.
    Zhu W; Wang X; Lv Y; Chen H; Chen X; Li X; Zhu S; Lin Z; Wang G
    Langenbecks Arch Surg; 2023 May; 408(1):215. PubMed ID: 37247018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison.
    Helton WS; Maves R; Wicks K; Johansen K
    Arch Surg; 2001 Jan; 136(1):17-20. PubMed ID: 11146768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Coil or Plug Embolization Ineffectively Attain Gastric Variceal Decompression or Occlusion: Results of a 26-Patient Retrospective Study.
    Lakhoo J; Bui JT; Lokken RP; Ray CE; Gaba RC
    J Vasc Interv Radiol; 2016 Jul; 27(7):1001-11. PubMed ID: 27106732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of LSPD versus TIPS for the treatment of esophagogastric variceal bleeding in cirrhosis.
    Chen B; Wang J; Sheng W; Ma B; Xu P; Cheng X; Cheng W; Cai C; Wang G; Pan W; Wan C; Zheng C; Cheng P; Zhang J
    Surg Endosc; 2024 Apr; 38(4):2106-2115. PubMed ID: 38438672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
    Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparison of efficacies between transjugular intrahepatic portosystemic shunt versus portoazygos devascularization in the treatment of portal hypertension with variceal bleeding].
    Xu XB; Chu JG; Huang H; Zhang HY; Zhang HY; Liu CL; Xiao M; Zhang H; Feng ZQ; Zhao G
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2542-5. PubMed ID: 23158794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.
    Xue H; Zhang M; Pang JX; Yan F; Li YC; Lv LS; Yuan J; Palikhe M; Li WZ; Wang ZL
    World J Gastroenterol; 2012 Dec; 18(48):7341-7. PubMed ID: 23326143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.
    Chen L; Xiao T; Chen W; Long Q; Li R; Fang D; Wang R
    Liver Int; 2009 Aug; 29(7):1101-9. PubMed ID: 19386025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.
    Yan H; Xiang Z; Zhao C; Luo S; Liu H; Li M; Huang M
    Eur Radiol; 2024 Jul; 34(7):4697-4707. PubMed ID: 38006453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.